The music publishing and rights community must immediately recalibrate its valuation models for music biopics following the unprecedented commercial dominance of Lionsgate and Universal’s Michael. This film has not merely entered the conversation; it has obliterated the previous benchmark set by Bohemian Rhapsody to become the highest-grossing music biopic of all time. Crossing $911.9 million worldwide, Jaafar Jackson’s portrayal of Michael Jackson has redefined the financial ceiling for the genre, signaling a massive shift in how audiences consume music history on screen. This surge directly impacts songwriters, estate managers, and rights holders who now face a new era where biopic potential can generate nearly double the revenue of previous top-tier contenders.
A New Global Benchmark for Biopic Revenue
Directed by Antoine Fuqua and written by John Logan, this Lionsgate and Universal co-production has officially surpassed Bohemian Rhapsody’s total gross. The film secured $358.6 million at the domestic box office and $553.3 million internationally. Universal generated $540.5 million of the international total after acquiring foreign theatrical and ancillary rights. The film arrives in Japan today, a territory that could push Michael past $1 billion worldwide. If achieved, it would make Michael only the second film to cross that threshold at the 2026 global box office, following Universal’s Super Mario Galaxy Movie. By comparison, the Freddie Mercury biopic Bohemian Rhapsody grossed $216.6 million domestically and $694.3 million internationally for a $910.9 million global total. Both films were produced by Graham King, meaning King has now broken his own all-time box office record for music biopics.
Records Set and Turbulent Production History
The film has set a string of records in addition to its overall gross, including the largest global opening weekend ever for a music biopic, the highest-grossing domestic biopic of all time, and the most successful biopic ever in France, surpassing La Vie en Rose. Forty international markets surpassed Bohemian Rhapsody’s lifetime gross, including Brazil, France, and Mexico. It is also Lionsgate’s highest-grossing theatrical release ever worldwide. The road to release was not without turbulence. Lionsgate was forced to undertake $50 million in reshoots after the Jackson estate identified a key issue with a plot point in the screenplay concerning one of Jackson’s accusers, who was not meant to be dramatised in the film. The film stars Jaafar Jackson, Michael Jackson’s nephew, in the title role.
What to Watch for the Next Quarter
Publishers and rights holders must watch the Japanese market closely as the film arrives there today. The territory could push the film past $1 billion worldwide, cementing its status as a historic anomaly in the 2026 global box office. Stakeholders should also monitor Graham King’s future projects, as he has now established a new ceiling for music biopic profitability that will likely influence acquisition strategies for the next decade. The commercial success of Michael Jackson, who sold an estimated 350 million records worldwide and holds the record for the best-selling album of all time with Thriller, suggests that legacy artist biopics will remain the most lucrative asset class for film studios.
SOURCE TYPE: TRADE
For editorial consideration and industry coverage inquiries, contact [email protected]
